ArticleRadiation oncology (London, England)2026
MRI-enhanced online adaptive radiotherapy by virtual integration of a standalone MRI simulator and CBCT-based treatment delivery.
Article in Radiation oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeMR-guided radiotherapy (MRgRT) offers superior soft-tissue contrast and enables adaptive treatments which improve tumor targeting and organ-at-risk sparing. However, integrated MR-Linac systems remain financially and logistically inaccessible for many hospitals. To address this gap, we implemented a modular MRgRT workflow - termed the "Virtual MR-Linac"- which decouples MR imaging and treatment delivery, enabling daily adaptive radiotherapy (ART) using diagnostic-quality MRI. MATERIALS AND
methodsBetween November 2023 and January 2025, 31 male patients with pelvic lymph node metastases were treated using this workflow. Daily MR scans were acquired in treatment position using a 1.5T MR scanner. Contours were adapted on 2D T2 turbo-spin-echo images, while synthetic CTs generated from T1 DIXON sequences were used for dose calculation. Adapted plans were delivered on a C-arm Linac using CBCT imaging for positioning. Quality assurance included independent Monte Carlo dose recalculations, automated plan parameters verification and a plan complexity check using in-house scripting.
resultsAcross 99 adapted fractions, plan adaptation improved dosimetric outcomes, with a median 14% increase in Planning Target Volume (PTV) coverage and a 7% reduction in bowel D1cc (dose to 1 cc). Median times for MR imaging, contouring, and planning were 12, 12, and 20 min, respectively.
conclusionsThe Virtual MR-Linac approach enables high-quality ART to compensate for inter-fractional motion without the costs and complexity of integrated systems. It improves resource utilization, maintains patient comfort, and offers a flexible, scalable solution for clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.